Call for resources: ThinkWell is inviting researchers to submit evidence on the cost of delivering immunization services

The Immunization Delivery Cost Catalogue (IDCC) is the most comprehensive, standardized global evidence on the cost of delivering vaccines, covering 317 unit costs from 68 studies published between 2005 and early 2019. The IDCC supports global and country immunization stakeholders in answering the question: “What are the unit costs of vaccine delivery across different low and middle-income countries and through various delivery strategies?”

To ensure the IDCC remains current and relevant, ThinkWell is currently updating the systematic review by adding cost evidence published since 2019. We welcome researchers to share with us any studies they have conducted on the cost of delivering immunization. Contributions do not need to have been published in a peer-reviewed journal, and can include reports, presentations, or other kinds of resources as well, as long as they meet the following requirements:

  • Include a unit cost of delivery of immunization services
  • Be based on primary data from a low or middle income country
  • In English, French, Spanish, or Portuguese
  • Published between 2019 and today

We welcome any submissions via immunizationeconomics@thinkwell.global by the 31st of January 2024.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

New evidence on the costing the delivery of COVID-19 vaccines in Mozambique and the Philippines

ThinkWell has released two new reports on the cost of delivering COVID-19 vaccines in Mozambique and the Philippines, aiming to support governments and address the knowledge gap on the cost of these vaccination programs. In partnership with the Universidade Eduardo Mondlane and Ateneo de Manila University, ThinkWell conducted retrospective, bottom-up costing studies, as well as … Read More

Submissions Open for Special Issue of Vaccines on Estimating Vaccines’ Value and Impact

Estimating the value and public health impact of vaccines is critical to ensure evidence-based policy decision making in nearly all stages, from vaccine development to the introduction/implementation of vaccines in low-resource settings. To foster public health equity, as well as estimate value to local and national economies, concerted efforts are needed to increase the understanding … Read More

New Evidence Shows Investments in Vaccination Produce Even Greater Returns than Previously Thought

This article originally appeared on Gavi’s website.  The Decade of Vaccine Economics (DoVE) Project, carried out by the Johns Hopkins Bloomberg School of Public Health’s International Vaccine Access Center (IVAC) for nearly ten years, has computed the return-on-investment for vaccines preventing ten infectious diseases in 94 low- and middle-income countries, including 73 countries that have received support from … Read More